Leland Gershaw
Equity research analyst · Oppenheimer
Earnings calls
1
Nov 4, 2026 – Nov 4, 2026
Stocks asked about
1
Questions
1
Firm rating actions
0
on these stocks, from news
Coverage
Companies whose earnings calls Leland Gershaw asked questions on (from Lician's transcripts).
Questions on earnings calls
- URGN earnings call · UroGen Pharma Ltd.Nov 4, 2026 · 1 question
- 27:19
“Just two from us. First, what would you like to say? I just wanted to drill in a bit, Mark, on your comments about, you know, sort of the type of patient who would be the go-to for Zestory versus another Terp. It sounds like, you know, given the data, Zestory can treat, you…”
- 27:19
Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.
Oppenheimer rating actions on these stocks
From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Leland Gershaw. We do not use licensed rating databases.
No rating action by Oppenheimer on these stocks in the headlines we store yet.